Indian American ex-Pfizer employee convicted of insider trading on Covid-19 medicine clinical trials

NEW YORK (TIP): A 44-year-old Indian American former Pfizer employee has been convicted for insider trading by a federal court in New York for his scheme to reap illicit profits by trading on information about the results of a Covid-19 medicine’s clinical trials by the pharmaceutical giant.
Following a two-week trial, Amit Dagar of Hillsborough in New Jersey was convicted of one count of securities fraud and one count of conspiracy to commit securities fraud last week, the Department of Justice said in a statement.
According to court documents, in November 2021, Dagar participated in an insider trading scheme to reap illicit profits from options trading based on inside information about the results of clinical trials of Paxlovid, a medicine used to treat Covid-19. At that time, he was an employee of Pfizer and assisted in managing the data analysis in specific clinical drug trials.
On November 4, 2021, Dagar learned that a Pfizer trial of Paxlovid- a medicine designed to treat mild to severe COVID-19 infection- had produced positive results.
The results were confidential and were meant to remain so until Pfizer publicized them the next day.
Later that same day, while the results remained confidential, he purchased short-dated, out-of-the-money Pfizer call options that expired days and weeks later.
Federal prosecutors said Dagar also tipped a close friend, who purchased similar call options.
The following day, Pfizer publicly released the results of its Paxlovid study before the market opening, and its stock price increased substantially, opening — and eventually closing — more than 10 per cent higher than the previous day’s closing price.
In the following weeks, Dagar sold his Pfizer call options for profits of more than USD 270,000, federal prosecutors alleged.
“As the jury’s swift verdict shows, the proof at trial was overwhelming that Amit Dagar stole information about Paxlovid from his employer, Pfizer, and used that illegal edge to profit in the stock market,” told US Attorney Damian Williams. “Combatting the corruption of our financial markets continues to be a top priority of this Office,” he added. A conviction in securities fraud carries a maximum sentence of 20 years in prison, while that in conspiracy to commit securities fraud carries a maximum sentence of five years in prison.